Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

HRTX

HRTX News

Newswire

08:26

Heron Therapeutics Expands Portfolio with Aponvie Approval for Postoperative Nausea and Vomiting.

08:21

Heron Therapeutics' APONVIE approved as only FDA-approved IV NK-1 antagonist for PONV prevention.

08:16

Heron Therapeutics' APONVIE Included in Newly Released PONV Guidelines

17:10

Heron Therapeutics: Stagnant Cash Cow, Blockbuster That Wasn't - Steer Clear

08:16

Heron Therapeutics shares surge 12.97% premarket driven by insider buying and institutional investments in Q3.

View More

About HRTX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More